ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,221Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 59

$941K Total Retail Price of All Prescriptions

Rank: 6 out of 59

657 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 657 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,427 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 748 548 1 2
SIMVASTATIN 513 425 2 1
LOSARTAN POTASSIUM 378 301 3 19
LEVOTHYROXINE SODIUM 375 301 4 3
METFORMIN HCL 357 272 5 6
OMEPRAZOLE 289 210 6 7
HYDROCODONE-ACETAMINOPHEN 267 128 S3 7 5
ALENDRONATE SODIUM 239 231 8 20
ZOLPIDEM TARTRATE 222 179 9 17
CRESTOR 221 147 10 23
GABAPENTIN 209 156 11 13
ATORVASTATIN CALCIUM 189 151 12 15
TRAMADOL HCL-ACETAMINOPHEN 173 134 13 77
AMLODIPINE BESYLATE 169 136 14 4
FUROSEMIDE 166 136 15 8
CARVEDILOL 162 118 16 31
METOPROLOL SUCCINATE 159 129 17 12
AZITHROMYCIN 130 96 18 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 126 103 19 18
PRAVASTATIN SODIUM 125 92 20 21
LOSARTAN-HYDROCHLOROTHIAZIDE 125 102 20 39
MELOXICAM 119 95 22 26
DIOVAN 110 86 23 38
FLUTICASONE PROPIONATE 109 88 24 34
TRAMADOL HCL 109 93 24 10
NAPROXEN 104 73 26 69
GLIMEPIRIDE 100 87 27 47
CLOPIDOGREL 98 73 28 35
WELCHOL 97 62 29 184
TRILIPIX 95 76 30 120
TAMSULOSIN HCL 94 89 31 27
SERTRALINE HCL 93 63 32 22
PEN NEEDLE 91 56 33 92
METOPROLOL TARTRATE 89 64 34 9
HYDROCHLOROTHIAZIDE 86 67 35 11
GLYBURIDE-METFORMIN HCL 86 44 R 35 59
CITALOPRAM HBR 83 77 37 25
NEXIUM 83 55 37 14
LEVEMIR FLEXPEN 82 74 39 125
GLIPIZIDE 81 71 40 52
LANTUS SOLOSTAR 80 47 41 103
LANTUS 67 53 42 53
LOVAZA 66 42 43 74
FENOFIBRATE 66 52 43 86
GLYBURIDE 65 46 R 45 48
TRIAMCINOLONE ACETONIDE 64 57 46 160
DEXILANT 62 29 47 217
NASONEX 60 36 48 126
DIOVAN HCT 59 48 49 65
BYSTOLIC 57 40 50 136
GLIPIZIDE-METFORMIN 57 38 50 224
POTASSIUM CHLORIDE 57 41 50 16
ACTOS 57 46 50 73
MECLIZINE HCL 56 52 54 72
ONGLYZA 53 44 55 181
SYNTHROID 53 43 55 100
FAMOTIDINE 52 50 57 66
CIPROFLOXACIN HCL 51 41 58 36
JANUVIA 51 31 58 45
AMLODIPINE BESYLATE-BENAZEPRIL 50 39 60 61
IBUPROFEN 50 26 60 62
BENICAR 50 30 60 238
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.